Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common stock, $0.00001 par value per share
-
Shares outstanding
-
60,389,334
-
Number of holders
-
224
-
Total 13F shares, excl. options
-
51,230,952
-
Shares change
-
+2,237,180
-
Total reported value, excl. options
-
$3,958,124,330
-
Value change
-
+$152,934,374
-
Put/Call ratio
-
2.14%
-
Number of buys
-
107
-
Number of sells
-
-112
-
Price
-
$77.39
Significant Holders of Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST) as of Q4 2021
280 filings reported holding TWST - Twist Bioscience Corp - Common stock, $0.00001 par value per share as of Q4 2021.
Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST) has 224 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51,230,952 shares
of 60,389,334 outstanding shares and own 84.83% of the company stock.
Largest 10 shareholders include Capital World Investors (4,522,700 shares), BlackRock Inc. (4,333,902 shares), VANGUARD GROUP INC (4,323,608 shares), ARK Investment Management LLC (3,767,203 shares), FMR LLC (2,453,120 shares), Nikko Asset Management Americas, Inc. (2,351,257 shares), Sumitomo Mitsui Trust Holdings, Inc. (2,351,257 shares), JPMORGAN CHASE & CO (1,812,645 shares), Jackson Square Partners, LLC (1,810,941 shares), and Invesco Ltd. (1,751,804 shares).
This table shows the top 224 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.